AVID RADIOPHARMACEUTICALS, INC.

Company Information

Company Name
AVID RADIOPHARMACEUTICALS, INC.
Address
AVID RADIOPHARMACEUTICALS, INC.
3624 Market Street, 5th Floor
Philadelphia, PA, 19104
Phone
n/a
URL
n/a
DUNS
170631720
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$1,952,108.00
6
STTR Phase I
$500,000.00
1

Award List

  1. AV1: F-18 Radiopharmaceutical for Imaging Amyloid Plaque

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The long-term goal of this project is the development of radiopharmaceuticals for diagnosis of Alzheimer's disease (AD). The project is driven by the hypothesis ...

    SBIR Phase I 2005 Department of Health and Human Services
  2. Radiopharmaceuticals for Imaging Brain Synuclein

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The long-term goal of this project is the development of radiopharmaceuticals for diagnosis of Dementia with Lewy Bodies (DLB). DLB is the second most common cau ...

    SBIR Phase I 2005 Department of Health and Human Services
  3. Clinical Evaluation of IMPY SPECT for Diagnosis of Alzheimer's

    Amount: $500,000.00

    DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is the most common cause of dementia in the elderly, with more than 4.5 million Americans currently suffering from the disease. Clinical ...

    STTR Phase I 2007 Department of Health and Human Services
  4. 18F-FP-DTBZ for PET Imaging of Beta Cell Mass in Diabetes

    Amount: $247,050.00

    DESCRIPTION (provided by applicant): Both Type I (T1D) and Type 2 (T2D) diabetes share a common pathophysiology - insufficient beta cell mass (BCM) to meet metabolic demands. Unfortunately, advances i ...

    SBIR Phase I 2007 Department of Health and Human Services
  5. Development of Radiopharmaceuticals for Imaging Brain Tau Pathology

    Amount: $498,812.00

    DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is the most common cause of dementia in the elderly, with more than 4.5 million Americans currently suffering from the disease. Clinical m ...

    SBIR Phase I 2008 Department of Health and Human Services
  6. 18F-AV-133, A Novel Radiopharmaceutical for Differential Diagnosis of Dementia

    Amount: $498,750.00

    DESCRIPTION (provided by applicant): Dementia, with its most prevalent subforms Alzheimer's disease (AD), dementia with Lewy bodies (DLB), and vascular dementia, is a very substantial medical and so ...

    SBIR Phase I 2008 Department of Health and Human Services
  7. 18F-AV-45 PET Imaging of Amyloid in PD with Cognitive Impairment

    Amount: $507,496.00

    DESCRIPTION (provided by applicant): Dementia associated with PD (PDD) is common (affecting up to 80% of patients long-term) and highly disabling. Informative biomarkers are urgently needed to underst ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government